Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

NCT01132417 is registered in ClinicalTrials.gov with King Faisal University as lead sponsor.

NCT NCT01132417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01132417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance
Lead sponsor
King Faisal University
Phase
Observational
Overall status
Suspended
Start date
September 30, 2009
Completion date
July 31, 2012
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, bacterial